thioridazine has been researched along with epidermal growth factor in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akiyama, S; Kuratomi, Y; Kuwano, M; Ohkuma, S; Ono, M; Shimada, T; Shiraishi, N | 1 |
| Steffen, AC; Sundberg, AL | 1 |
2 other study(ies) available for thioridazine and epidermal growth factor
| Article | Year |
|---|---|
Thioridazine enhances lysosomal accumulation of epidermal growth factor and toxicity of conjugates of epidermal growth factor with Pseudomonas exotoxin.
Topics: ADP Ribose Transferases; Bacterial Toxins; Biological Transport; Calmodulin; Cell Compartmentation; Drug Synergism; Epidermal Growth Factor; Exotoxins; Female; HeLa Cells; Humans; Hydrogen-Ion Concentration; Lysosomes; Microscopy, Electron; Pseudomonas aeruginosa Exotoxin A; Thioridazine; Virulence Factors | 1986 |
Enhancing the effect of radionuclide tumor targeting, using lysosomotropic weak bases.
Topics: Amantadine; Ammonium Chloride; Antimalarials; Antipsychotic Agents; Antiviral Agents; Astatine; Carcinoma, Squamous Cell; Cell Line, Tumor; Chloroquine; Epidermal Growth Factor; Glioma; Humans; Iodine Radioisotopes; Radioimmunotherapy; Radioisotopes; Recombinant Fusion Proteins; Thioridazine | 2007 |